Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer

Clinical trial NCT02048943 · WITHDRAWN

Trial details

NCT number: NCT02048943
Sponsor: Roswell Park Cancer Institute
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2015-03-01
Primary completion: 2015-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.